[go: up one dir, main page]

DK164049C - 1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse - Google Patents

1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse

Info

Publication number
DK164049C
DK164049C DK474684A DK474684A DK164049C DK 164049 C DK164049 C DK 164049C DK 474684 A DK474684 A DK 474684A DK 474684 A DK474684 A DK 474684A DK 164049 C DK164049 C DK 164049C
Authority
DK
Denmark
Prior art keywords
pyrrolidionons
aminoalkyl
benzyl
procedures
preparation
Prior art date
Application number
DK474684A
Other languages
English (en)
Other versions
DK164049B (da
DK474684A (da
DK474684D0 (da
Inventor
Karl-Heinz Weber
Gerhard Walther
Claus Schneider
Dieter Hinzen
Franz Josef Kuhn
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK474684D0 publication Critical patent/DK474684D0/da
Publication of DK474684A publication Critical patent/DK474684A/da
Publication of DK164049B publication Critical patent/DK164049B/da
Application granted granted Critical
Publication of DK164049C publication Critical patent/DK164049C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK474684A 1983-10-04 1984-10-03 1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse DK164049C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3336024 1983-10-04

Publications (4)

Publication Number Publication Date
DK474684D0 DK474684D0 (da) 1984-10-03
DK474684A DK474684A (da) 1985-04-05
DK164049B DK164049B (da) 1992-05-04
DK164049C true DK164049C (da) 1992-09-28

Family

ID=6210932

Family Applications (1)

Application Number Title Priority Date Filing Date
DK474684A DK164049C (da) 1983-10-04 1984-10-03 1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse

Country Status (27)

Country Link
US (4) US4767759A (da)
EP (1) EP0136658B1 (da)
JP (2) JPS6094959A (da)
KR (1) KR910007882B1 (da)
AR (1) AR243503A1 (da)
AU (1) AU565839B2 (da)
CA (1) CA1242193A (da)
CS (2) CS244148B2 (da)
DD (1) DD227963A5 (da)
DE (2) DE3336024A1 (da)
DK (1) DK164049C (da)
ES (3) ES8505652A1 (da)
FI (1) FI78464C (da)
GR (1) GR80546B (da)
HK (1) HK75892A (da)
HU (1) HU193229B (da)
IE (1) IE58155B1 (da)
IL (1) IL73125A (da)
NO (1) NO165239C (da)
NZ (1) NZ209759A (da)
PH (1) PH23764A (da)
PL (2) PL145637B1 (da)
PT (1) PT79306B (da)
SG (1) SG44192G (da)
SU (2) SU1373318A3 (da)
YU (2) YU43858B (da)
ZA (1) ZA847755B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
JPH02500365A (ja) * 1987-05-20 1990-02-08 ザムボン グループ エス.ピー.エー. 認識補助作用を持つ化合物
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
DE68903425T2 (de) * 1988-05-20 1993-03-25 Zambon Spa Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
AU625157B2 (en) * 1989-01-17 1992-07-02 F. Hoffmann-La Roche Ag Cyclohexaneacetamide derivatives
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
WO1997036900A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU740616B2 (en) * 1996-06-21 2001-11-08 Syntroleum Corporation Synthesis gas production system and method
MY118075A (en) 1996-07-09 2004-08-30 Syntroleum Corp Process for converting gas to liquids
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
WO1999019277A1 (en) * 1997-10-10 1999-04-22 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons with separation of water into oxygen and hydrogen
WO2000051609A1 (en) * 1999-03-02 2000-09-08 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
WO2000051610A1 (en) * 1999-03-02 2000-09-08 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
AU3386500A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
RU2195447C1 (ru) * 2001-07-31 2002-12-27 Кубанский государственный технологический университет 1-(4-нитрофенил)-4-n-x-аминопирролидоны-2, проявляющие рострегулирующую и антистрессовую активность, и способ их получения
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
WO2005021539A1 (en) * 2003-09-03 2005-03-10 Pfizer Japan, Inc. Benzimidazolone compounds having 5-ht4 receptor agonistic activity
MXPA06014486A (es) 2004-06-15 2007-03-01 Pfizer Derivados de acido carboxilico de bencimidazolona.
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
RU2330660C2 (ru) * 2005-12-01 2008-08-10 ГОУ ВПО Военно-медицинская академия им. С.М. Кирова ПРИМЕНЕНИЕ ИМИДАЗО[4,5-b]ИНДОЛ-2-ТИОНА ДЛЯ ЗАЩИТЫ ОТ ВОЗДЕЙСТВИЯ ГЕМИЧЕСКОЙ ГИПОКСИИ
RU2327458C1 (ru) * 2007-02-19 2008-06-27 Открытое акционерное общество "Щелковский витаминный завод" Новая препаративная форма вещества, обладающего ноотропной и нейромодуляторной активностью, и способ ее получения
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL295221A (da) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
DK164049B (da) 1992-05-04
HK75892A (en) 1992-10-09
DK474684A (da) 1985-04-05
EP0136658A2 (de) 1985-04-10
FI843856L (fi) 1985-04-05
KR850003393A (ko) 1985-06-17
DE3477922D1 (en) 1989-06-01
EP0136658A3 (da) 1985-06-05
FI78464C (fi) 1989-08-10
NO165239B (no) 1990-10-08
NO843979L (no) 1985-04-09
PT79306B (de) 1986-11-13
IL73125A (en) 1988-10-31
PL253280A1 (en) 1986-02-11
JPH0739387B2 (ja) 1995-05-01
NO165239C (no) 1991-01-16
PL249852A1 (en) 1985-09-10
IE58155B1 (en) 1993-07-14
DD227963A5 (de) 1985-10-02
AU3383484A (en) 1985-04-18
JPH046684B2 (da) 1992-02-06
ES536469A0 (es) 1985-06-01
YU199086A (en) 1987-10-31
YU43858B (en) 1989-12-31
PL145630B1 (en) 1988-10-31
CS153784A2 (en) 1985-08-15
GR80546B (en) 1985-02-05
US5073671A (en) 1991-12-17
SU1306472A3 (ru) 1987-04-23
US4767759A (en) 1988-08-30
IE842519L (en) 1985-04-04
ES539883A0 (es) 1985-11-16
NZ209759A (en) 1989-04-26
YU43901B (en) 1989-12-31
JPH04261152A (ja) 1992-09-17
CS410891A3 (en) 1992-08-12
AU565839B2 (en) 1987-10-01
PT79306A (de) 1984-11-01
AR243503A1 (es) 1993-08-31
SG44192G (en) 1992-09-04
ES8601878A1 (es) 1985-11-16
JPS6094959A (ja) 1985-05-28
DE3336024A1 (de) 1985-04-18
FI843856A0 (fi) 1984-10-02
PL145637B1 (en) 1988-10-31
HUT35641A (en) 1985-07-29
KR910007882B1 (ko) 1991-10-04
HU193229B (en) 1987-08-28
SU1373318A3 (ru) 1988-02-07
DK474684D0 (da) 1984-10-03
ES8601877A1 (es) 1985-11-16
FI78464B (fi) 1989-04-28
CA1242193A (en) 1988-09-20
YU169684A (en) 1987-10-31
CS244148B2 (en) 1986-07-17
PH23764A (en) 1989-11-03
ES539884A0 (es) 1985-11-16
ZA847755B (en) 1986-06-25
EP0136658B1 (de) 1989-04-26
IL73125A0 (en) 1984-12-31
ES8505652A1 (es) 1985-06-01
US4833140A (en) 1989-05-23
US4996224A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
DK164049C (da) 1-benzyl-aminoalkyl-pyrrolidiononer, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse
DK362787A (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK290986D0 (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK573384A (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK209585A (da) Pyrrolobenzimidazoler, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser samt mellemprodukter
DK288184D0 (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK170785A (da) 4-substituerede-piperazin-2-carboxylsyre-derivater og farmaceutisk acceptable salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse
DK522983D0 (da) Arylphenyletherderivater og syreadditionssalte deraf samt fremgangsmade til fremstilling deraf
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK435588A (da) Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse
DK164109C (da) Lh-rh-antagonister og deres farmaceutisk acceptable syreadditionssalte og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende disse
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK491385D0 (da) 1,2,4-triazolocarbamater og deres syreadditionssalte, fremgangsmaader til deres fremstilling og laegemidler indeholdende saadanne forbindelser
DK572785A (da) Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
DK457787D0 (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK610084A (da) Imidazolderivater eller syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK209384D0 (da) 4-phenyl-tetrahydro-furano-pyridiner og syreadditionssalte deraf,fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK158518C (da) Phenylpiperazinderivater og syreadditionssalte deraf, fremgangsmaade til fremstilling deraf samt praeparater indeholdende derivaterne
DK165444C (da) Meta- og para-isopropenyl-alfa,alfa-dimethylbenzylamin og syreadditionssalte deraf samt fremgangsmaader til fremstilling deraf
DK400085A (da) Aminosyrederivater, fremgangsmaader til fremstilling heraf og laegemidler indeholdende saadanne derivater
DK290584A (da) Propan-2-ol-derivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK245787D0 (da) Nicotinsyrederivater, fremgangsmaade til fremstilling deraf og praeparater med fungicid virkning indeholdende disse derivater
DK120185D0 (da) Substituerede isochroman- og oxepinforbindelser, deres syreadditionssalte, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
DK189786D0 (da) 4-aminoalkylidensubstituerede 3-aryl-5(4h)-isoxazoloner, fremgangsmaader til fremstilling deraf, samt laegemidler indeholdende disse forbindelser og deres anvendelse
DK164453C (da) Dibenzooeb,daathiopyran-6-carboxylsyreforbindelser, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK